Kuangli Bio-Tech Holdings CoTPE:6431 69 Altman Z-Score is 0.94 as of Jul. 03, 2026, which is 55% below its 10-year median of 2.08. GuruFocus rates TPE:6431 with a GF Score™ of 69/100 and a GF Value™ of NT$11.73 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,928 Consumer Packaged Goods companies, Kuangli Bio-Tech Holdings Co ranks worse than 85.22% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 0.94 is in distress zone. This implies bankruptcy possibility in the next two years.
Kuangli Bio-Tech Holdings Co has a Altman Z-Score of 0.94, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Kuangli Bio-Tech Holdings Co's Altman Z-Score or its related term are showing as below:
TPE:6431'
s Altman Z-Score Range Over the Past 10 Years
Min: 0.45 Med: 2.08 Max: 11.98
Current: 0.94
During the past 13 years, Kuangli Bio-Tech Holdings Co's highest Altman Z-Score was 11.98. The lowest was 0.45. And the median was 2.08.
Kuangli Bio-Tech Holdings Co (TPE:6431) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6431 vs PG, CL, KVUE: Altman Z-Score Comparison
For the Household & Personal Products subindustry, Kuangli Bio-Tech Holdings Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kuangli Bio-Tech Holdings Co Altman Z-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kuangli Bio-Tech Holdings Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Kuangli Bio-Tech Holdings Co's Altman Z-Score falls into.
Kuangli Bio-Tech Holdings Co Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Kuangli Bio-Tech Holdings Co (TPE:6431) has a Altman Z-Score of 0.94 as of Jul. 03, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. This is 55% below median its historical median of 2.08. Over the past decade, Kuangli Bio-Tech Holdings Co's Altman Z-Score has ranged from 0.45 to 11.98. According to the industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #1643 out of 1928 companies in the Consumer Packaged Goods industry, placing it in the top 85.2%.
Is Kuangli Bio-Tech Holdings Co's Altman Z-Score too high?
Kuangli Bio-Tech Holdings Co's current Altman Z-Score of 0.94 is 55% below median its 10-year median of 2.08. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 11.98. The Consumer Packaged Goods industry median Altman Z-Score is 2.83. Kuangli Bio-Tech Holdings Co's value of 0.94 is 66.8% below this industry median. Based on the distribution chart, Kuangli Bio-Tech Holdings Co ranks #1643 out of 1928 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Kuangli Bio-Tech Holdings Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kuangli Bio-Tech Holdings Co's Altman Z-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #1643 out of 1928 companies for Altman Z-Score. This places Kuangli Bio-Tech Holdings Co in the lower half of its industry. The industry median Altman Z-Score is 2.83. Kuangli Bio-Tech Holdings Co's value of 0.94 is 66.8% below this benchmark. Historically, Kuangli Bio-Tech Holdings Co's own Altman Z-Score has ranged from 0.45 to 11.98 over the past decade. While the company's 10-year median is 2.08 vs. the industry median of 2.83, Kuangli Bio-Tech Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Consumer Packaged Goods company?
The median Altman Z-Score among Consumer Packaged Goods companies is 2.83, based on 1,928 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kuangli Bio-Tech Holdings Co's current Altman Z-Score of 0.94 is 66.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median Altman Z-Score is 2.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kuangli Bio-Tech Holdings Co's current Altman Z-Score is 0.94, which is 55% below median its own 10-year median of 2.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kuangli Bio-Tech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co (TPE:6431) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$11.73, compared to a current price of NT$18.20 — trading 55.2% above its estimated fair value. The current Altman Z-Score is 0.94, which is 55% below median its 10-year median of 2.08 and 66.8% below the Consumer Packaged Goods industry median of 2.83. Kuangli Bio-Tech Holdings Co's overall GF Score™ is 69/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Kuangli Bio-Tech Holdings Co (TPE:6431), the current Altman Z-Score is 0.94 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kuangli Bio-Tech Holdings Co (TPE:6431) Overvalued in 2026?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co stock appears to be overvalued.
The current stock price of NT$18.20 is trading 55.2% above its estimated GF Value™ of NT$11.73.
GuruFocus considers Kuangli Bio-Tech Holdings Co to be Significantly Overvalued.
Key valuation signals for TPE:6431:
Altman Z-Score: 0.94 (55% below median its 10-year median of 2.08)
GF Value™: NT$11.73 vs. price of NT$18.20 (55.2% above fair value)
Industry Position: 66.8% below the Consumer Packaged Goods median (#1643 of 1928)
No single metric tells the full story. See the TPE:6431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.
69GF Score
Get the complete analysis for TPE:6431
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6431 has been successfully added to your 
